Identification of Fusion Gene Breakpoints is Feasible and Facilitates Accurate Sensitive Minimal Residual Disease Monitoring on Genomic Level in Patients With PML-RARA, CBFB-MYH11,...

by Julius Lukes, Jr., Lucie Winkowska, Martina Zwyrtkova, Julia Starkova, Lucie Sramkova, Jan Stary, Jan Trka, Jan Zuna, Marketa Zaliova
Published 2020-12-01